secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2026-06-25T22:49:24+00:00
Accession:  0001999371-26-013527
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne to be acquired by Merck KGaA for $73.00 per share in all-cash deal
-----------------------------------------------------------------------------

- Merck KGaA to acquire Bio-Techne (TECH) for $73.00 per share in cash.
- Termination fees: Company pays $230.5M for superior proposal; Parent pays $576.1M for antitrust failure.
- Retention bonuses: CEO Kelderman $2.12M, CFO Hippel $1.54M, plus Geist $1.16M, Bohnen $0.97M, Crouse $0.91M.
- Closing requires shareholder approval, HSR and antitrust clearances; outside date Mar 25, 2027, extendable.
- Board unanimously recommends the merger; subject to no-shop and fiduciary-out provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000199937126013527/0001999371-26-013527-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000199937126013527/tech-8k_062326.htm
  HTML page:      https://secwatch.observer/filing/0001999371-26-013527

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer